Advertisement

PentaVision

Publications

Glaucoma Physician

Ophthalmology Management

Ophthalmology Management

Retinal Physician

Retinal Physician

Glaucoma Physician

Glaucoma Physician

Ophthalmic Professional

Ophthalmic Professional

The Ophthalmic ASC

The Ophthalmic ASC

Presbyopia Physician

Presbyopia Physician

Corneal Physician

Corneal Physician

New Retinal Physician

New Retinal Physician

Article

Addressing Surgeon Hesitancy in Glaucoma Surgery

Patients are open to minimally invasive procedures when they are presented as alternatives to drops.

By: Inder Paul Singh, MD, Savak “Sev” Teymoorian, MD, MBA, Christine Funke, MD

Glaucoma Physician January 1, 2026 Page(s): 16-17, 20

5 Key Takeaways

1

Minimally invasive glaucoma surgery (MIGS) offers significant benefits over traditional eye drops, including reduced complications and improved patient satisfaction.
2

Many ophthalmologists hesitate to recommend early surgical intervention despite evidence showing it improves visual outcomes and minimizes risks.
3

Patients generally trust their doctors' recommendations and are open to advanced procedures when well-informed about their options.
4

The shift towards interventional glaucoma care emphasizes early procedural intervention to prevent disease progression and reduce treatment burden.
5

Educating patients about the risks of chronic drop use is essential for aligning their perceptions with clinical goals and improving treatment adherence.

Savak “Sev” Teymoorian

Specialties: Ophthalmology

Bio: Savak “Sev” Teymoorian, MD, MBA, is a physician author whose work focuses on glaucoma management and surgical decision-making. In Glaucoma Physician, he has written about surgeon hesitancy in glaucoma surgery, including the role of minimally invasive procedures as alternatives to long-term topical drop therapy.

Contributions:

https://glaucomaphysician.net/issues/2024/june/real-world-pearls-for-idose-tr-implantation/

https://glaucomaphysician.net/issues/2026/january/addressing-surgeon-hesitancy-in-glaucoma-surgery/

Christine Funke

Affiliations: Barnet Dulaney Perkins

Specialties: Ophthalmology

Bio: Christine Funke, MD, is affiliated with Barnet Dulaney Perkins in Phoenix, Arizona, and focuses on glaucoma care. In a Glaucoma Physician discussion from the 2026 American Society of Cataract and Refractive Surgeons meeting, she addressed interventional glaucoma and the shift toward earlier procedural treatment.

Teymoorian, MD, MBA

Specialties: Ophthalmology

Bio: Teymoorian, MD, MBA, is an ophthalmology author who wrote on drug delivery innovations for glaucoma treatment in Ophthalmology Management. Their published work centers on glaucoma therapy and ophthalmic disease management, including topics such as medication adherence, procedural treatment approaches, and cytomegalovirus retinitis.

Savak Sev Teymoorian

Specialties: Surgery

Bio: Savak Sev Teymoorian, MD, MBA, is a medical doctor with expertise in glaucoma surgery. He is a contributing author to medical discussions on the management of glaucoma, emphasizing early surgical intervention over traditional reliance on eye drops. His work focuses on improving patient outcomes through minimally invasive procedures and addressing clinician hesitancy regarding glaucoma surgeries. Dr. Teymoorian contributes to advancing the understanding of therapeutic strategies aimed at managing intraocular pressure and preventing vision loss in glaucoma patients.

Savak “Sev” Teymoorian

Specialties: Ophthalmology

Bio: Savak “Sev” Teymoorian, MD, MBA, is a glaucoma specialist focused on advancing therapeutic approaches for glaucoma management. His expertise includes clinical experience with novel sustained-release implants for glaucoma, including the recently FDA-approved iDose TR implant, which delivers travoprost via an intracameral sustained-release system. He contributes insights to improve patient adherence challenges and overall quality of life in glaucoma care by integrating innovations in microinvasive glaucoma surgery and procedural pharmaceuticals.